GI CONNECT has summarised the highlights of the recent ASCO and WCGIC 2018 meetings for you.
GI CONNECT has summarised the highlights of the recent ASCO and WCGIC 2018 meetings for you.
Dr Joleen Hubbard is Deputy Director of Clinical Research and Academic Affairs for the Allina Health Cancer Institute in Minneapolis, Minnesota. She was previously Assistant Professor of Medical Oncology at Mayo Clinic. She completed medical school and residency at the University of Minnesota and haematology/oncology training at Mayo Clinic, Rochester, Minnesota. Dr Hubbard specialises in the treatment of gastrointestinal cancers, focusing on colorectal cancer. Dr Hubbard is the PI of several phase I clinical trials, investigating novel agents for gastrointestinal cancers. Her research interests also include geriatric oncology with a special interest in clinical and biologic markers of frailty. She serves as a member of the Cancer in the Elderly, as well as the Health Reported Outcomes and Translational Research committees for the North American Alliance of Clinical Trials in Oncology Network.
Advisory boards: Bayer, Merck, BeiGene, Incyte
Research funding to institution: Merck, Boston Biomedical, Treos Bio, Senhwa Pharmaceuticals, Bayer, Incyte, TriOncology, Seattle Genetics, Hutchison MediPharma, Pionyr Immunotherapeutics, Trovogene, G1 Therapeutics, Roche
Exploring the impacts of age, ethnicity, socioeconomic status, and access to healthcare on patients with colorectal cancer
Aligning real-world evidence with clinical trial data
Moderado por los Oncology Brothers. Episodio 1 de una serie de podcast de video de 3 partes.
Moderado pelos Oncology Brothers. Episódio 3 da série de podcasts em vídeo de 3 partes
Moderado por los Oncology Brothers. Episodio 3 de una serie de podcast de 3 partes.
Moderado pelos Oncology Brothers. Episódio 2 da série de podcasts em vídeo de 3 partes